Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting Enzyme

A Corrigendum to this article was published on 07 March 1970

Abstract

THE venom from Bothrops jararaca contains enzymes which liberate kinins from plasma kininogen1. Ferreira2 found that the venom also contained a peptidic fraction (bradykinin potentiating factor, BPF) which potentiated the actions of bradykinin on various isolated organs and on the blood pressure of the cat. This potentiating action was later correlated with an inhibition of kinin-destroying enzymes3–5. Recently BPF has been separated into several different active fractions and the amino-acid composition of nine purified peptides has been established6. The structure of the smallest of the peptides (V-3A), a pentapeptide, has been established (pGa-Lys-Trp-Ala-Pro) and the material has been synthesized7. Ferreira, Bartelt and Greene6 also measured the bradykinin-potentiating activity of these different purified peptides on the isolated ileum from the guinea-pig as an indication of their ability to inhibit kininases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Roche e Silva, M., Beraldo, W. T., and Rosenfeld, G., Amer. J. Physiol., 156, 261 (1949).

    Article  Google Scholar 

  2. Ferreira, S. H., Brit. J. Pharmacol. Chemother., 24, 163 (1965).

    Article  CAS  Google Scholar 

  3. Ferreira, S. H., and Roche e Silva, M., Experientia, 21, 347 (1965).

    Article  CAS  Google Scholar 

  4. Ferreira, S. H., in Hypotensive Peptides (edit. by Erdös, G., Back, N., and Sicuteri, F.), 356 (Springer-Verlag, NY, 1966).

    Book  Google Scholar 

  5. Ferreira, S. H., and Vane, J. R., Brit. J. Pharmacol. Chemother., 29, 367 (1967).

    Article  CAS  Google Scholar 

  6. Ferreira, S. H., Bartelt, D. C., and Greene, L. J., J. Biol. Chem. (in the press).

  7. Greene, L. J., Stewart, J. M., and Ferreira, S. H., J. Biol. Chem. (in the press).

  8. Bakhle, Y. S., Nature, 220, 919 (1968).

    Article  ADS  CAS  Google Scholar 

  9. Bakhle, Y. S., Reynard, A. M., and Vane, J. R., Nature, 222, 956 (1969).

    Article  ADS  CAS  Google Scholar 

  10. Ng, K. K. F., and Vane, J. R., Nature, 216, 762 (1967).

    Article  ADS  CAS  Google Scholar 

  11. Ng, K. K. F., and Vane, J. R., Nature, 218, 144 (1968).

    Article  ADS  CAS  Google Scholar 

  12. Oparil, S., Sanders, C. A., and Haber, E., Fed. Proc., 28, 580 (1969).

    Google Scholar 

  13. Regoli, D., and Vane, J. R., Brit. J. Pharmacol. Chemother., 23, 351 (1964).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The erratum article can be found online at https://doi.org/10.1038/225981c0

Rights and permissions

Reprints and permissions

About this article

Cite this article

FERREIRA, S., GREENE, L., ALABASTER, V. et al. Activity of Various Fractions of Bradykinin Potentiating Factor against Angiotensin I Converting Enzyme. Nature 225, 379–380 (1970). https://doi.org/10.1038/225379a0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/225379a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing